| Paired donor interchange to avoid ABO-incompatible living donor liver transplantation | 271 |
| Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma | 73 |
| Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas | 61 |
| Post-transplant endothelial progenitor cell mobilization via CXCL10/CXCR3 signaling promotes liver tumor growth | 88 |
| Effect of donor steatosis on liver biochemistry and significance of body mass index and alanine aminotransferase in predicting steatosis | 118 |
| Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: A 20-year experience | 149 |
| Can positron emission tomography with the dual tracers [ 11C]acetate and [ 18F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma? | 173 |
| The Hong Kong experience and challenges | 26 |
| Post-rituximab Burkitt transformation of PTLD: Loss of CD20 expression accompanied by a switch in light-chain expression | 175 |
| Improvising hepatic venous outflow and inferior vena cava reconstruction for combined heart and liver and sequential liver transplantations | 56 |
| Bile duct anastomotic stricture after right lobe adult-to-adult living donor liver transplantation | 126 |
| A decade of right liver adult-to-adult living donor liver transplantation: The recipient mid-term outcomes | 172 |
| Feasibility of laparoscopic re-resection for patients with recurrent hepatocellular carcinoma | 50 |
| Life made easy: Simplifying reconstruction for dual portal veins in adult right lobe live donor liver transplantation | 163 |
| Surgical treatment of the primary and secondary tumors of the liver | 33 |
| Hepatitis B vaccination and preemptive treatment of hepatitis B virus in liver transplantation | 144 |
| Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes | 210 |
| Pre-transplant live liver donor evaluation and perioperative care. Protocol of Queen Mary Hospital, University of Hong Kong | 97 |
| The effect of donor age on the outcome of Liver Transplant in patients with Hepatitis B Virus Infection | 50 |
| Low-volume deceased donor liver transplantation alongside a strong living donor liver transplantation service | 60 |
| Effects of the liver volume and donor steatosis on errors in the estimated standard liver volume | 148 |
| Donor quality of life | 12 |
| Survival outcomes on resection of hepatocellular carcinoma with postoperative complications - a propensity score-matched analysis | 65 |
| Management of solitary recurrent HCC: Is re-resection justified for those with adverse prognostic factors? | 66 |
| Rapid measurement of indocyanine green clearance by pulse spectrophotometry: a validation study in 70 patients with Child-pugh A liver function | 148 |
| Recurrence determined 10-year survival of hepatocellular carcinoma after hepatectomy | 70 |
| Prospective study on donor quality of life before and after right lobe adult-to-adult live donor liver transplantation | 115 |
| New insights after the first 1000 liver transplantations at The University of Hong Kong | 81 |
| Perpetuating proficiency in donor right hepatectomy for living donor liver transplantation | 62 |
| Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors | 53 |
| Living donor versus deceased donor liver transplantation for early unresectable hepatocellular carcinoma: same criteria, different outcome | 107 |
| Resection technique for live-donor transplantation | 49 |
| Monday blues of deceased-donor liver transplantation | 144 |
| Risk of recurrent hepatocellular carcinoma in chronic hepatitis B patients after liver transplantation | 70 |
| Activation of AMPK by Metformin Attenuates Marginal Graft Injury via Promoting Mitochondrial Biogenesis | 100 |
| Adult Living Donor Right Hepatectomy and Recipient Operation | 73 |
| Adult-to-adult living donor liver transplantation: Operative techniques to optimize the recipient's outcome | 55 |
| Simultaneous implantation of bilateral liver grafts in living donor liver transplantation by fusion venoplasty | 48 |
| Single-centre experience of liver transplantation for familial amyloidotic polyneuropathy of non-Val30Met variants in Chinese patients | 177 |
| The right may not be always right: Biliary anatomy contraindicates right lobe live donor liver transplantation | 137 |
| Technical considerations for radical resection of a primary leiomyosarcoma of the vena cava | 68 |
| Defining an optimal surgical strategy for synchronous colorectal liver metastases: Staged versus simultaneous resection? | 73 |
| Re-resection for metachronous primary hepatocellular carcinoma: is it justified? | 55 |
| Fatal graft-versus-host disease after unrelated cadaveric liver transplantation due to donor/recipient human leucocyte antigen matching (Letter to the Editor) | 38 |
| The role and limitation of living donor liver transplantation for hepatocellular carcinoma | 112 |
| Liver transplantation | 14 |
| Hepatitis B vaccination in patients receiving antiviral monotherapy after liver transplantation for chronic hepatitis B | 42 |
| Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis | 59 |
| Liver stiffness and histological features in healthy persons, and patients with occult hepatitis B, chronic active hepatitis B, and hepatitis B-related cirrhosis. | 45 |
| Excellent outcomes of hepatitis B core antibody positive donors with oral antiviral agent alone in liver transplantation | 78 |
| Resection of solitary lymph node metastasis for hepatocellular carcinoma after hepatectomy. | 71 |
| Long-term outcome of lamivudine mono-prophylaxis after liver transplantation in Hepatitis B patients | 80 |
| Laparoscopic versus open liver resection for elderly patients with malignant liver tumors: A single-center experience | 64 |
| Internal hernia of the small bowel after right-lobe live donor liver transplantation | 140 |
| Overestimating the liver volume for subjects with low body weight | 117 |
| Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: A single-center experience | 59 |
| Outcome of laparoscopic versus open hepatectomy for colorectal liver metastases | 53 |
| Comparison of cryptogenic and hepatitis B related hepatocellular carcinoma | 38 |
| Comparable outcomes of hepatocellular carcinoma after deceased donor vs. living donor liver transplantation | 45 |
| Hemolysis and methemoglobinemia due to hepatitis E virus infection in patient with G6PD deficiency | 147 |
| Open portal vein embolization | 29 |
| SMALL VOLUME DECEASED DONOR LIVER TRANSPLANTATION ALONGSIDE LIVING DONOR LIVER TRANSPLANTATION | 16 |
| Improved anterior hepatic transection for isolated hepatocellular carcinoma in the caudate | 62 |
| A case of laparoscopic hepatectomy for recurrent hepatocellular carcinoma | 188 |
| Recipient body size does not matter in pediatric liver transplantation | 89 |
| Indications and contraindication of liver resection | 32 |
| The use of hepatitis B core antibody positive donors for liver transplantation does not lead to inferior survival | 44 |
| Portal inflow and pressure changes in right liver living donor liver transplantation including the middle hepatic vein | 124 |
| Toward current standards of donor right hepatectomy for adult-to-adult live donor liver transplantation through the experience of 200 cases | 179 |
| Increased applicability of liver transplantation in Hong Kong | 117 |
| Impact of antiviral therapy on the survival outcome of patients after hepatectomy for hepatitis B-related hepatocellular carcinoma | 126 |
| Efficacy of post liver transplant hepatitis B booster vaccination in chronic hepatitis B recipients with prior immune response | 85 |
| Samaritan donor interchange in living donor liver transplantation | 59 |
| Effect of changing paradigm for management of hepatocellular carcinoma on the long-term survival of patients with hepatocellular carcinoma | 115 |
| General principles of organ transplantation | 21 |
| NLRP3 inflammasome exacerbated fatty graft injury through activation of telomere-independent RAP1/KC axis after LDLT | 38 |
| Bioethics of living donor liver transplantation | 28 |
| Media coverage of liver transplant events promotes donations from the deceased | 23 |
| Surgical options for treatment of hepatocellular carcinoma | 15 |
| De novo sarcoma of donor origin in a liver allograft determined by microsatellite analysis: A short report | 198 |
| Recurrent hepatitis B infection after liver transplantation for hepatitis B related diseases in Asian population: long term results of a single centre | 154 |
| Recovering the recovering liver graft | 54 |
| Clinicopathological study of renal biopsies after liver transplantation | 41 |
| Entecavir monotherapy is effective in viral suppression after liver transplantation for hepatitis B | 122 |
| Prediction of hospital mortality after liver transplantation for acute liver failure | 111 |
| Salvage Transplantation for Recurrent Hepatocellular Carcinoma within Milan Criteria: Is It Worthwhile? | 42 |
| Bile duct anastomotic stricture after pediatric living donor liver transplantation | 194 |
| Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability | 64 |
| Survival analysis of hepatic resection for breast cancer metastases in Chinese women | 71 |
| Value of live donor liver transplantation experience in major hepatectomy for hepatocellular carcinoma | 109 |
| High-intensity focused ultrasound for hepatocellular carcinoma: A single-center experience | 213 |
| Prospective blinded study on INTRAOPEATIVE ICG retention test for major hepatectomy – A direct functional measurement of future liver remnant | 110 |
| Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: Implications for salvage liver transplant | 121 |
| Simplifying Living donor liver transplantation | 99 |
| Accurate Prediction of Milan Criteria: The Role of Dual Tracer 18F-FDG and 11C-Acetate PET-CT Scan. | 64 |
| A retrospective study on risk factors associated with failed endoscopic treatment of biliary anastomotic stricture after right-lobe living donor liver transplantation with duct-to-duct anastomosis | 77 |
| Survival outcomes of right-lobe living donor liver transplantation for patients with high model for end-stage liver disease scores | 42 |
| Biliary complications in liver transplantation | 175 |
| Split graft liver transplant for paediatric patients in Hong Kong | 122 |
| Advantage of primary liver transplantation for hepatocellular carcinoma within up-to-7 criteria with microvascular invasion | 122 |
| Association between glucose 6-phosphate dehydrogenase (G6PD) deficiency and fatal outcome of hepatitis E infection in middle-aged men (Letter to the Editor) | 117 |
| Resection of hepatocellular carcinoma after combined treatment with transarterial chemoembolization and sorafenib: a case report and literature review | 44 |
| Evaluation of 11C-Acetate and 18F-FDG PET Scan with contrast CT on pathological and prognosis prediction in HCC Patients before Liver Transplantation - a Single-Institute Experience | 78 |
| Donor quality of life before and after adult-to-adult right liver live donor liver transplantation | 203 |
| Excellent outcomes of severely steatotic grafts in liver transplantation | 54 |
| Liver transplantation for hepatocellular carcinoma | 69 |
| Impact of extent of surgical resection on the outcomes of hepatocellular carcinoma based on prognostic factors | 49 |
| Bile duct anastomotic stricture after adult-to-adult right lobe living donor liver transplantation | 136 |
| Risks factors associated with failed endoscopic treatment for biliary anastomotic stricture after right lobe living donor liver transplantation | 70 |
| Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma | 178 |
| NLRP3 inflammasome initiated liver graft injury through telomere-independent repressor activator protein1 (RAP1) / keratinocyte chemoattractant (KC) axis | 67 |
| Long Term Survival Analysis of Hepatectomy for Neuroendocrine Tumour Liver Metastases | 78 |
| Acute appendicitis presenting with distal duodenal obstruction | 127 |
| Modulation of graft vascular inflow guided by flowmetry and manometry in liver transplantation | 134 |
| Clinical experience in managing Post Transplant Lymphoproliferative Disease (PTLD) in paediatric patients after liver transplant | 134 |
| Donor perspective of right lobe adult-to-adult live donor liver transplantation | 257 |
| Late recurrence of hepatocellular carcinoma after liver transplantation | 178 |
| Implications for management of Mycobacterium tuberculosis infection in adult-to-adult live donor liver transplantation | 147 |
| Metformin attenuated steatotic graft injury via promoting mitochondrial biogenesis after liver transplantation | 33 |
| High-intensity focused ultrasound ablation: An effective bridging therapy for hepatocellular carcinoma patients | 89 |
| Late recurrence of HCC after liver transplantation | 165 |
| Role of portal vein embolisation in hepatocellular carcinoma management and its effect on recurrence: an intention-to-treat analysis | 216 |
| Historical perspective of living donor liver transplantation | 173 |
| Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation | 154 |
| Simultaneous implantation of bilateral liver grafts in living donor liver transplantation with fusion venoplasty | 43 |
| Alleviating the burden of small for size graft in right liver living donor liver transplantation | 30 |
| Does hepatitis B seroconversion affect survival outcome in patients with hepatitis B related hepatocellular carcinoma? | 48 |
| Patients with preoperative hepatorenal syndrome (HRS) have comparable long-term outcomes after live-donor liver transplantation (LDLT) | 141 |
| Simplifying hepatic venous outflow reconstruction in sequential living donor liver transplantation | 192 |
| Hepatitis B vaccination in patients receiving oral antiviral therapy without hepatitis B immunoglobulin after liver transplant | 313 |
| Child-Pugh Parameters and Platelet Count as an Alternative to ICG Test for Assessing Liver Function for Major Hepatectomy | 36 |
| Increasing the recipient-benefit to donor-risk ratio by lowering the graft size requirement for Living Donor Liver Transplantation | 60 |
| Outcomes of endo-radiological approach to management of bile leakage after right lobe living donor liver transplantation | 52 |
| Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study | 54 |
| Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion | 181 |
| Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation | 101 |
| Operative outcomes of adult-to-adult right lobe live donor liver transplantation: A comparative study with cadaveric whole-graft liver transplantation in a single center | 107 |
| Liver Failure and Liver Transplantation | 17 |
| Survival advantage of primary liver transplantation for resectable hepatocellular carcinoma with vascular invasion | 140 |
| Technical note on ALPPS for a patient with advanced hepatocellular carcinoma associated with invasion of the inferior vena cava | 41 |
| Recipient body size dose not matter in paediatric liver transplantation | 30 |
| Pure Laparoscopic Versus Open Left Lateral Sectionectomy for Hepatocellular Carcinoma: A Single-Center Experience | 90 |
| Pseudo pseudocyst after right lobe live door liver transplantation | 27 |
| Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B | 127 |
| Head-to-head comparison of the right and left liver graft in adult-to-adult live donor liver transplantation | 131 |
| Acute phase circulating micoRNAs predict tumor recurrence and survivals of hepatocellular carcinoma patients after liver transplantation | 86 |
| Liver transplantation – Hong Kong and Macau | 12 |
| Retrohepatic vena cava deroofing in living donor liver transplantation for caudate hepatocellular carcinoma | 63 |
| Operative outcomes of adult-to-adult right lobe live donor liver transplantation: a comparative study with cadaveric whole-graft liver transplantation in a single center | 136 |
| Low Volume Deceased Donor Liver Transplantation Alongside Living Donor Liver Transplantation | 58 |
| Does spontaneous tumor rupture always has an adverse prognostic impact on patients with resectable hepatocellular carcinoma? | 104 |
| Remnant left liver size and recovery of living right liver donors | 53 |
| Liver transplantation for fulminant hepatic failure: As early as necessary and as late as possible | 44 |
| Live liver donor mortality [1] | 46 |
| Validating graft and standard liver size predictions in right liver living donor liver transplantation | 88 |
| Oral nucleoside/nucleotide analogs without hepatitis b immune globulin after liver transplantation for hepatitis b | 63 |
| Validation of graft and standard liver size predictions in right liver living donor liver transplantation | 154 |
| Introduction to Clinical Research | 20 |
| Estimating liver weight of adults by body weight and gender | 199 |
| Asian perspective of liver transplantation for hepatocellular carcinoma | 26 |
| Current status of management of liver cancer | 22 |
| Radiological prognosticators of hepatocellular carcinoma treated by hepatectomy | 47 |
| Outcomes of central bisectionectomy for hepatocellular carcinoma | 62 |
| Efficacy of a pre-S containing vaccine in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B | 196 |
| Long term survival analysis of hepatic resection for breast cancer metastases | 40 |
| Effect of side and size of graft on surgical outcomes of adult-to-adult live donor liver transplantation | 133 |
| Histological outcome after liver transplantation for chronic hepatitis B using oral antiviral therapy alone without hepatitis B immune globulin | 68 |
| Reply | 16 |
| Single centre experience of liver transplantation for familial amyloidotic polyneuropathy of non-Val30Met variant in Chinese patient | 133 |
| Hepatic resection for incidentaloma | 114 |
| Inhibitor development after liver transplantation in congenital factor VII deficiency | 50 |
| Inflammasome Exacerbated Fatty Graft Injury Through Activation of Telomere-Independent RAP1/KC Axis After LDLT | 37 |
| Excellent outcomes of severely steatotic grafts in liver transplantation | 61 |
| Head-to-head comparison of the right and left liver graft in adult-to-adult live donor liver transplantation | 141 |
| Applicability of histidine-tryptophan-ketoglutarate solution in right lobe adult-to-adult live donor liver transplantation | 154 |
| Impact of graft type on the survival outcome of salvage Liver Transplantation for recurrent Hepatocellular Carcinoma | 68 |
| Retransplantation using living-donor right-liver grafts | 100 |
| Long-term outcomes of entecavir monotherapy after liver transplantation for hepatitis B: 5 years data | 36 |
| Interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation in patients with chronic hepatitis B infection | 103 |
| Acute liver failure. Contemporary management: prevention, treatment, and patient management | 18 |
| Start writing radomized controlled trial | 23 |
| Bioethical basis of liver transplantation for hepatocellular carcinoma | 15 |
| Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: Implications for the development of a refined staging system | 71 |
| Radiofrequency ablation versus transarterial chemoembolization for unresectable solitary hepatocellular carcinomas sized 5-8 cm | 85 |
| Outcomes of Living Donor Transplantation: The Eastern Perspective | 42 |
| Rapid onset Chilaiditi's sign on top of fulminant hepatic failure | 155 |
| Working up donors for high-urgency and elective adult-to-adult live donor liver transplantation | 171 |
| Effects of donor steatosis on liver biochemistry and significance of body mass index in predicting steatosis | 69 |
| Safety of ALPPS procedure by the anterior approach for hepatocellular carcinoma | 73 |
| Use of sorafenib in recurrent hepatocellular carcinoma (HCC) after liver transplantation | 95 |
| A decade of right liver adult-to-adult living donor liver transplantation - the recipients mid-term outcomes | 86 |
| Rapid measurement of indocyanine green retention by pulse spectrophotometry: A validation study in 70 patients with Child-Pugh A cirrhosis before hepatectomy for hepatocellular carcinoma | 75 |
| Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus | 68 |
| AMP-activated protein kinase attenuates marginal liver graft injury via promoting mitochondrial biogenesis and respiratory function | 58 |
| Current status of liver transplantation | 25 |
| The effect of wide resection margin in patients with intrahepatic cholangiocarcinoma: A single-center experience | 61 |
| Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil to lamivudine | 100 |
| Emergency re-routing of anterior sector venous outfow for right lobe living donor liver transplantation including the middle hepatic vein | 46 |
| Transplantation of a 2-year-old deceased-donor liver to a 61-year-old male recipient | 77 |
| Clinical factors affecting rejection rates in liver transplantation | 68 |
| Patients with Pre-Operative Hepatorenal Syndrome (HRS) Have Poorer Long-Term Survival Outcome after Living Donor Liver Transplantation (LDLT) | 48 |
| Increasing the recipient-benefit to donor-risk ratio by lowering the graft size requirement for living donor liver transplantation | 36 |
| Donor quality of life before and after adult-to-adult live donor liver transplantation | 107 |
| Analysis of long-term survival after hepatectomy for isolated liver metastasis of gastrointestinal stromal tumour | 72 |
| Liver transplantation for hepatocellular carcinoma: The Hong Kong experience | 139 |
| Validating graft and standard liver size predictions in right liver living donor liver transplantation | 145 |
| The effect of high intensity focused ultrasound therapy in patients with HCC smaller than 3 cm | 39 |
| Management of recurrent hepatocellular carcinoma after liver transplant – a single center experience | 27 |
| Increasing the recipient benefit/donor risk ratio by lowering the graft size requirement for living donor liver transplantation | 65 |
| Living donor liver transplantation: the Asian perspective | 37 |
| Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter | 53 |
| MARS treatment for a patient presenting with acquired hepatic glutamine synthetase deficiency after orthotopic liver transplantation | 152 |
| Liver transplantation for acute-on-chronic liver failure | 192 |
| Acute pancreatitis induced by transarterial chemoembolization: a single-center experience of over 1500 cases | 150 |
| Results of percutaneous transhepatic cholecystostomy for high surgical risk patients with acute cholecystitis | 136 |
| Surgical wound infection | 350 |
| Wait and transplant for stage 2 hepatocellular carcinoma with deceased-donor liver grafts | 54 |
| Resurgence of biliary cast syndrome | 164 |
| Case Report of Relay Liver Transplantation With Graft Infected With Hepatitis B Virus | 59 |
| Identification of a novel TTR Gly67Glu mutant and the first case series of familial transthyretin amyloidosis in Hong Kong Chinese | 159 |
| Reply to "Wait and transplant for stage 2 hepatocellular carcinoma with deceased-donor liver grafts: how long should we wait?" (Correspondence) | 37 |
| Liver Resection for De Novo Hepatocellular Carcinoma Complicated by Pyogenic Liver Abscess: A Clinical Challenge | 73 |
| 11C-acetate and 18F-FDG dual tracer PET scan with contrast CT provide the most accurate histopathology prediction in HCC patients - a study of explant histopathology in the model of liver transplantation | 151 |
| Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria | 181 |
| Reply: Underestimated role of 18F-FDG PET for HCC evaluation and promise of 18F-FDG PET/MR imaging in this setting | 63 |
| Minimalist approach to donor hepatectomy | 50 |
| Can Dual Tracer 18F-FDG and 11C-Acetate PET Scan Predict Venous Permeation in Hepatocellular Carcinoma? | 58 |
| Significance of hepatitis B virus genotype in liver transplantation for chronic hepatitis B | 116 |
| Durability of small-for-size living donor allografts | 52 |
| Living donor liver transplantation for hepatocellular carcinoma across Milan criteria | 153 |
| Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine | 214 |
| NLRP3 inflammasome induced liver graft injury through activation of telomere-independent RAP1/KC axis | 121 |
| Functional outcome following low anterior resection with total mesorectal excision in the elderly | 147 |
| Portal inflow and pressure changes in right liver living donor liver transplantation including middle hepatic vein | 166 |
| Liver transplant for paediatric oncology patient | 13 |
| Long-term follow up of Hepatitis B virus-specific immune response in liver transplant patient receiving third-generation hepatitis B vaccine | 146 |
| Side and size of grafts on surgical outcomes of adult-to-adult live donor liver transplantation | 104 |
| Salvage living donor liver transplantation for recurrent hepatocellular carcinoma: salvaging the unsalvageable? | 108 |
| Principle of Organ Transplantation | 16 |
| Evaluation of survival after Primary Liver Transplantation for Hepatocellular Carcinoma within UCSF criteria | 47 |
| Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver | 190 |
| Outcomes of liver resection for hepatocellular carcinoma with obstructive jaundice | 70 |
| Outcomes of side-to-side conversion hepaticojejunostomy for biliary anastomotic stricture after right-liver living donor liver transplantation | 72 |
| Meckel's diverticulum in action | 85 |
| Asia's first combined liver transplant and aortic valve replacement | 52 |
| NLRP3 inflammasome induced graft injury regulated by telomere-independent repressor activator protein 1 (RAP1) / keratinocyte chemoattractant (KC) axis after LDLT | 36 |
| Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma | 178 |
| Flowmetry-based portal inflow manipulation for a small-for-size liver graft in a recipient with spontaneous splenorenal shunt | 114 |
| Tailoring donor hepatectomy per segment 4 venous drainage in right lobe live donor liver transplantation | 120 |
| Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: A retrospective study | 59 |
| Outcome of living donors | 34 |
| Hepatic resection for incidentaloma | 174 |
| Pure laparoscopic hepatectomy versus open hepatectomy for hepatocellular carcinoma in 110 patients with liver cirrhosis: a propensity analysis at a single center | 63 |
| Scoring for organ allocation | 34 |
| Timely liver transplantation is essential for the survival of paediatric patients with hepatopulmonary syndrome | 139 |
| Current status of downstaging of hepatocellular carcinoma before liver transplantation | 27 |
| A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma | 208 |
| Rescue Living-donor Liver Transplantation for Liver Failure Following Hepatectomy for Hepatocellular Carcinoma | 54 |
| Living donor versus deceased donor liver transplantation for small unresectable hepatocellular carcinoma: same criteria, different outcome | 139 |
| Treatment strategy for recurrent hepatocellular carcinoma: salvage liver transplantation, repeated hepatic resection, or radiofrequency ablation | 87 |
| Survival advantage of primary liver transplantation for resectable hepatocellular carcinoma with vascular invasion within up-to-7 criteria | 142 |
| Combined major liver resection and radiofrequency ablation for multifocal hepatocellular carcinoma | 61 |
| Liver Transplantation | 15 |
| Splanchnic hemodynamics in liver regeneration after right liver living donor liver transplantation | 182 |
| Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis | 55 |
| NLRP3 inflammasome regulated by telomere-independent Repressor Activator Protein1(RAP1) induced graft injury after LDLT | 73 |
| Treatment strategy to improve long-term survival for hepatocellular carcinoma smaller than 5 cm: Major hepatectomy vs minor hepatectomy | 62 |
| Management of spontaneously ruptured hepatocellular carcinomas in the radiofrequency ablation era | 67 |
| High intensity focused ultrasound as a bridging therapy for patient with HCC - A hype or hope? | 114 |
| Short- and long-term impact of reoperation for complications after major hepatectomy for hepatocellular carcinoma | 54 |
| Safety of duct-to-duct biliary reconstruction in right-lobe live-donor liver transplantation without biliary drainage | 122 |
| Versatility and viability of hepatic venoplasty in live donor liver transplantation using the right lobe with the middle hepatic vein | 99 |
| Pediatric liver transplantation in Hong Kong-a domain with scarce deceased donors | 205 |
| Modified model for end stage liver disease score accurately predicts death or liver transplantation in acute flares of chronic hepatitis B | 141 |
| Hepatopancreatoduodenectomy for advanced hepatobiliary malignancies: a single-center experience | 47 |
| Risk factors and outcome of patients with pancreatic fistula after radical pancreaticoduodenectomy | 40 |
| Strategies for widening liver donor pool | 180 |
| The friendly incidental portal vein thrombus in liver transplantation | 49 |
| Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma | 56 |
| Donor quality of life before and after adult-to-adult live donor liver transplantation | 95 |
| Lowered Immune Cell Function in Liver Recipients Recovered From Posttransplant Lymphoproliferative Disease Who Developed Graft Tolerance | 61 |
| Recurrent pyogenic cholangitis | 77 |
| Comparable short and long term outcomes in living donor and deceased donor liver transplantation for patients with ultra high MELD scores | 55 |
| A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation | 111 |
| Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma | 57 |
| Hepatic resection for living donor transplantation | 150 |
| Head-to-head comparison of the right and left liver graft in adult-to-adult live donor liver transplantation | 153 |
| High-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients awaiting liver transplantation | 75 |
| Phase II study of an 'all-oral' regimen of capecitabine, idarubicin and cyclophosphamide for metastatic breast cancer - safety, efficacy and quality of life | 52 |
| A decade of right liver adult-to-adult live donor liver transplantation: mid-term outcomes | 141 |
| Comparisons of surgical outcomes and recurrence after liver transplantation in patients with Hepatitis B vs. Hepatitis C related hepatocellular carcinoma | 59 |
| Value of live donor liver transplantation experience in major hepatectomy for hepatocellular carcinoma | 113 |
| Lipid profiles of donors and recipients of liver transplant: like father like son | 46 |
| Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection | 63 |
| Best method of biliary reconstruction | 12 |
| Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: A protocol with early elimination of steroids and reduction of tacrolimus dosage | 118 |
| Resection of T4 HCC with surrounding structures | 83 |
| HCC recurrence after Liver Transplantation in Asia vs. Europe: which is the difference? | 68 |
| Long-term biological consequences of donor right hepatectomy including the middle hepatic vein in adult-to-adult live donor liver transplantation | 142 |
| Acute liver failure and liver transplant | 20 |
| Iatrogenic Chilaiditi's syndrome | 141 |
| AMP-activated protein kinase attenuated marginal liver graft injury via promoting mitochondrial biogenesis and respiratory function | 56 |
| Comparison of Survival Outcomes between Right Posterior Sectionectomy and Right Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Liver: A Single-Centre Experience | 92 |
| Outcomes including liver histology after liver transplantation for chronic hepatitis B using oral antiviral therapy alone | 134 |
| Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B - long term outcome | 71 |
| Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis | 152 |
| Safety of donor right hepatectomy without abdominal drainage: A prospective evaluation in 100 consecutive liver donors | 134 |
| Organ Transplantation (Liver) | 13 |
| Entecavir versus lamivudine prophylaxis without hepatitis B immune globulin after liver transplantation for chronic hepatitis B | 136 |
| Safety of perioperative aspirin in hepatocellular carcinoma patients undergoing hepatectomy | 91 |
| Comparable short- and long-term outcomes in living donor and deceased donor liver transplantations for patients with Model for End-stage Liver Disease scores ≥35 in a hepatitis-B endemic area | 66 |
| Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation | 43 |
| Retransplantation using living donor right liver graft | 127 |
| Renal cell carcinoma with inferior vena caval tumour thrombus: surgical management and clinical outcomes at a low-volume centre | 63 |
| Prevention of hepatitis B recurrence after liver transplantation | 30 |
| Liver transplant for biliary atresia is associated with a worse outcome: myth or fact? | 61 |
| Survival Analysis of Re-resection Versus Radiofrequency Ablation for Intrahepatic Recurrence After Hepatectomy for Hepatocellular Carcinoma | 227 |
| General principles of organ transplantation | 15 |
| Fairness of liver graft allocation under current HCC MELD score exception policy in Hong Kong | 144 |
| Primary treatment for hepatocellular carcinoma within UCSF criteria: comparing outcomes of deceased and living donor liver transplantation | 146 |
| Right liver adult-to-adult live donor liver transplantation in Hong Kong | 124 |
| Recurrence of hepatocellular cancer after liver transplantation: The role of primary resection and salvage transplantation in East and West | 76 |
| Wide resection margin improves survival in patients with early intrahepatic cholangiocarcinoma - a 22-year single center experience | 89 |
| Resection of T4 hepatocellular carcinomas with adjacent structures, is it justified? | 63 |
| Safety of donor right hepatectomy for live donor liver transplantation without abdominal drainage | 101 |
| Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection or radiofrequency ablation? | 54 |
| Feasibility of Laparoscopic Re-resection for Patients with Recurrent Hepatocellular Carcinoma | 56 |
| Recurrent pyogenic cholangitis | 162 |
| Alleviating the burden of small-for-size graft in right liver living donor liver transplantation through accumulation of experience | 194 |
| 11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan Criteria: surgeon's perspective | 114 |
| Impact of donor age on right lobe living donor liver transplantation in a single centre | 108 |
| Small-for-size liver graft and hepatocellular carcinoma recurrence | 21 |
| Use of liver stiffness measurement for liver resection surgery: correlation with indocyanine green clearance testing and post-operative outcome | 58 |
| Comparable surgical outcomes after downstaging of unresectable hepatocellular carcinoma - a propensity score analysis | 62 |
| Outcome of right liver living donor liver transplantation | 21 |
| Liver transplantation: a life-saving procedure following amatoxin mushroom poisoning | 62 |
| Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation | 174 |
| Rare cause of jaundice in a post liver transplant patient | 81 |
| Anterior approach for liver resections | 95 |
| Inflammasome exacerbated fatty graft injury with accumulation of myeloid-derived suppressor cells after living donor liver transplantation | 38 |
